Physiological Role
Platelets, or thrombocytes, are small cell fragments produced by megakaryocytes in the bone marrow. Their lifespan in the bloodstream is approximately ten days, after which they are cleared by the spleen and liver.
Their primary role is to ensure primary haemostasis. When a vascular injury occurs, platelets adhere to exposed subendothelium, activate and aggregate to form a platelet plug. This process constitutes the first line of defence against bleeding. Platelets also release growth factors involved in tissue repair.
Beyond coagulation, platelets play a role in innate immune response and inflammation regulation. They interact with leukocytes and release mediators that modulate the inflammatory response. This immunological dimension makes platelet count a richer parameter than a simple coagulation marker.
Reference Ranges
Depending on the biomarker, Singular ranges are based on a synthesis of nutritional or clinical reference points and longevity research. They do not replace your laboratory's reference values or your healthcare professional's advice.
Biological Significance
Platelet count reflects a balance between medullary production and peripheral consumption. A departure from the optimal range may reflect various physiological mechanisms that are useful to understand within a biological monitoring approach.
A platelet count below the optimal range may be associated with insufficient medullary production or increased peripheral consumption. Certain nutritional shortfalls, particularly in vitamin B12 or folates, can affect platelet production at the bone marrow level.
A platelet count above the optimal range is frequently observed in response to inflammation, physiological stress or a profound iron shortfall accompanied by low haemoglobin. This reactive thrombocytosis is generally transient and normalises once the triggering factor is corrected.
Longitudinal tracking of platelet count reveals individual trends. A significant variation between two assessments may signal a shift in haematological balance and warrant particular attention to associated parameters.
Influencing Factors
Iron status. A profound iron shortfall accompanied by low haemoglobin is among the causes of reactive thrombocytosis. The link is not observed in healthy people. In more than 22,000 blood donors, ferritin and platelet count are not correlated.
B vitamin status. Vitamins B9 and B12 are essential for megakaryocyte maturation. Insufficient intake can result in reduced platelet production and elevated mean corpuscular volume, a sign of impaired haematopoiesis.
Physical activity. Intense exercise triggers transient platelet mobilisation from the spleen and lungs, which can temporarily raise the circulating count. This effect normalises within hours following exertion.
Inflammation. Any acute or chronic inflammation stimulates thrombopoietin and interleukin-6 production, increasing platelet output. hs-CRP, measured by Singular, helps contextualise a platelet elevation within this framework.
Age and sex. Platelet count tends to decrease progressively with age, particularly in men. Women of childbearing age present slightly higher average values, a difference linked to hormonal influences and the menstrual cycle.
Hydration and haemodilution. Dehydration can concentrate blood and artificially raise platelet count. Maintaining normal hydration before a blood draw is recommended.
In the Singular Formula
Platelets are among the haematological parameters that Singular integrates into the overall biological profile. This marker conditions no rule of the formulation engine: it is measured and reported, without triggering any dosage adjustment.
Declaring a bleeding disorder caps the omega-3 (EPA+DHA) dosage. It is the only declaration that does: neither an antiplatelet agent nor an anticoagulant caps omega-3. A bleeding disorder, an antiplatelet agent or an anticoagulant declared instead leads to the withdrawal of several bioactives. Their influence on platelet aggregation is documented. Which bioactives are withdrawn depends on the declared treatment.
Two bioactives in the Singular formula concern this compartment. Omega-3 EPA+DHA modulate the lipid composition of platelet membranes and influence aggregation. Iron, included in the formula according to iron status, contributes to normal formation of red blood cells and haemoglobin.
Platelets complete the haematological profile reported to the member, with haemoglobin, mean corpuscular volume and ferritin. Iron, vitamin B12 and vitamin B9 adjustments follow other markers, detailed on their own pages.
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Bonaccio M et al. | 2016 | Cohort Study | Blood | View on PubMed |
Age-sex-specific ranges of platelet count and all-cause mortality: prospective findings from the MOLI-SANI study Research letter from the Italian MOLI-SANI cohort. It reports an association between platelet count and all-cause mortality in general-population adults, and raises the question of age- and sex-adapted benchmarks. | ||||
| Bonaccio M et al. | 2018 | Cohort Study | Platelets | View on PubMed |
Age- and sex-based ranges of platelet count and cause-specific mortality risk in an adult general population: prospective findings from the Moli-sani study Extension of the MOLI-SANI cohort to cause-specific mortality. A low platelet count is associated with total and cancer mortality, but not with cardiovascular mortality. A high platelet count is associated with no death risk in this cohort. | ||||
| Vinholt PJ et al. | 2016 | Cohort Study | Thrombosis Research | View on PubMed |
Platelet count is associated with cardiovascular disease, cancer and mortality: A population-based cohort study Danish cohort of 21,252 general-population adults. Mortality already rises within the usual laboratory interval: below 175 G/L and above 300 G/L. A platelet count between 100 and 200 G/L is associated with future cancer, but not with future bleeding. | ||||
| Msaouel P et al. | 2014 | Cohort Study | Haematologica | View on PubMed |
Abnormal platelet count is an independent predictor of mortality in the elderly and is influenced by ethnicity Analysis of over 36,000 outpatients aged 65 and older in an urban setting. An abnormal platelet count independently predicts mortality. The most discriminating threshold varies with the ethnic background of those followed. | ||||
| Gao LG et al. | 2013 | Meta-analysis | Atherosclerosis | View on PubMed |
Influence of omega-3 polyunsaturated fatty acid-supplementation on platelet aggregation in humans: a meta-analysis of randomized controlled trials Meta-analysis of 15 randomised controlled trials on platelet aggregation, not on platelet count. Omega-3 supplementation reduces aggregation in people in poor health status, but not in healthy people. The authors conclude it may not be effective in primary prevention. | ||||
| Holbro A et al. | 2017 | Observational Study | Vox Sanguinis | View on PubMed |
Iron deficiency and thrombocytosis Retrospective single-centre study of 22,046 blood donors and 130,345 paired measurements. No correlation between serum ferritin and platelet count is observed in these healthy people. The authors judge the effect negligible and call for studies in more severe anaemia and in inflammation. | ||||
| Warny M et al. | 2019 | Cohort Study | Journal of Thrombosis and Haemostasis | View on PubMed |
Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study Cohort of 108,521 Danes from the general population, followed for a median of eight years. Above 398 G/L, the top 5% carry a 1.8-fold risk of arterial thrombosis in the brain. No excess is measured in the heart or for venous thrombosis. | ||||
| van Zeventer IA et al. | 2021 | Cohort Study | Blood Advances | View on PubMed |
Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortality Dutch Lifelines cohort of 167,729 people. A lowered platelet count is associated with inferior overall survival, and the association strengthens markedly when low haemoglobin accompanies it. Most of the deaths observed are attributable to causes other than a haematological condition. | ||||